# CREATE Medicines funding rounds and investors

As of 14 Oct 2026, CREATE Medicines has raised $122M across 1 verified round on record; latest: $122 million Series B led by Arch Venture Partners, Hatteras Venture Partners and 1 other, announced 14 May 2026.

Create Medicines develops innovative immune programming therapies for treating cancer and autoimmune diseases.

Website: https://createmedicines.com  
Page: https://fireround.dev/companies/createmedicines.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-05-14 | Series B | $122 million | Arch Venture Partners, Hatteras Venture Partners, Newpath Partners | Alexandria Venture Investments | [createmedicines.com](https://createmedicines.com/news/create-medicines-announces-usd122-million-series-b-financing-to-advance-in-vivo-car-pipeline-in), [biospace.com](https://www.biospace.com/press-releases/create-medicines-announces-122-million-series-b-financing-to-advance-in-vivo-car-pipeline-in-autoimmune-disease-and-oncology-302771778.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.